| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-119 |
Sentence |
denotes |
Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene. |
| T1 |
0-119 |
Sentence |
denotes |
Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene. |
| T2 |
120-278 |
Sentence |
denotes |
Platelet glycoprotein (GP) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury. |
| T2 |
120-278 |
Sentence |
denotes |
Platelet glycoprotein (GP) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury. |
| T3 |
279-460 |
Sentence |
denotes |
The congenital absence of the receptor results in a bleeding disorder associated with "giant" platelets, a condition linking the expression of the complex to platelet morphogenesis. |
| T3 |
279-460 |
Sentence |
denotes |
The congenital absence of the receptor results in a bleeding disorder associated with "giant" platelets, a condition linking the expression of the complex to platelet morphogenesis. |
| T4 |
461-665 |
Sentence |
denotes |
To understand better the expression of the GP Ib-IX-V complex, studies were undertaken to define the essential genetic elements supporting the expression of the alpha-subunit of the complex (GP Ib alpha). |
| T4 |
461-665 |
Sentence |
denotes |
To understand better the expression of the GP Ib-IX-V complex, studies were undertaken to define the essential genetic elements supporting the expression of the alpha-subunit of the complex (GP Ib alpha). |
| T5 |
666-814 |
Sentence |
denotes |
GP Ib alpha promoter activity was evaluated by transfection of human erythroleukemia cells with reporter plasmids coding for the enzyme, luciferase. |
| T5 |
666-814 |
Sentence |
denotes |
GP Ib alpha promoter activity was evaluated by transfection of human erythroleukemia cells with reporter plasmids coding for the enzyme, luciferase. |
| T6 |
815-1031 |
Sentence |
denotes |
Studies were initiated with a fragment extending 2,738 nucleotides 5' to the transcription start site and lead to the identification of 253 nucleotides retaining full promoter activity in human erythroleukemia cells. |
| T6 |
815-1031 |
Sentence |
denotes |
Studies were initiated with a fragment extending 2,738 nucleotides 5' to the transcription start site and lead to the identification of 253 nucleotides retaining full promoter activity in human erythroleukemia cells. |
| T7 |
1032-1214 |
Sentence |
denotes |
In cells of nonhematopoietic lineage, human endothelial and HeLa cells, the GP Ib alpha promoter activity was no greater than background levels obtained with promoterless constructs. |
| T7 |
1032-1214 |
Sentence |
denotes |
In cells of nonhematopoietic lineage, human endothelial and HeLa cells, the GP Ib alpha promoter activity was no greater than background levels obtained with promoterless constructs. |
| T8 |
1215-1494 |
Sentence |
denotes |
Gel shift assays and site-directed mutagenesis studies defined essential GATA and Ets binding motifs 93 and 150 nucleotides upstream of the transcription start site, a finding which further substantiates these elements as important determinants of megakaryocytic gene expression. |
| T8 |
1215-1494 |
Sentence |
denotes |
Gel shift assays and site-directed mutagenesis studies defined essential GATA and Ets binding motifs 93 and 150 nucleotides upstream of the transcription start site, a finding which further substantiates these elements as important determinants of megakaryocytic gene expression. |
| T9 |
1495-1702 |
Sentence |
denotes |
The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream. |
| T9 |
1495-1702 |
Sentence |
denotes |
The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream. |